Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_36667 | 84 | 1.75 | Mlig455_016177 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.440 Region-enriched R2: 4.490/0.00556 |
Mlig455_016177 {REF} {Length: 3035} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=47.6]; Immunoglobulin domain [PF13927.8, score=47.0]; Immunoglobulin domain [PF00047.27, score=32.1]; Immunoglobulin domain [PF13895.8, score=27.4]; Natural killer cell receptor 2B4 [PF11465.10, score=26.4]; Immunoglobulin V-set domain [PF07686.19, score=23.5]} {Dmel: FBgn0259245, DIP-beta, Dpr-interacting protein beta, [Score=58.9, Expect=3e-09]} {Celegans: WBGene00006985, zig-8, Zwei Ig domain protein zig-8, [RH, Score=57.0, Expect=4e-09]} {Smed: dd_Smed_v6_21969_0_1, dd_Smed_v6_21969_0_1, [Score=72.0, Expect=6e-14]} {RNA1509_49618} {RNA1310_15195} {RNA815_58259} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -4.815 | 1.854 | 1.00000 | 1.00000 | |
RegionR2 | 4.49 | 1.854 | 0.00015 | 0.00556 | |
RegionR3 | -0.635 | 1.854 | 0.89478 | 1.00000 | |
RegionR4 | 0.536 | 1.854 | 0.59541 | 0.90932 | |
RegionR5 | -2.055 | 1.854 | 0.98414 | 1.00000 | |
RegionR6 | 1.339 | 1.854 | 0.26080 | 0.84837 | |
RegionR7 | 4.016 | 1.854 | 0.00037 | 0.01613 | |
RegionR8 | -2.875 | 1.854 | 0.99963 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 1.251 | 1.854 | 0.99983 | 1.00000 | |
RegenerationR2 | 0.061 | 1.854 | 0.92918 | 1.00000 | |
RegenerationR3 | 1.759 | 1.854 | 0.12393 | 0.54423 | |
RegenerationR4 | -1.669 | 1.854 | 0.10100 | 0.49231 | |
RegenerationR5 | 0.59 | 1.854 | 0.63679 | 0.92542 | |
RegenerationR6 | -0.213 | 1.854 | 0.81368 | 0.98441 | |
RegenerationBL | -3.983 | 1.854 | 1.00000 | 1.00000 | |
RegenerationTP | 0.001 | 1.854 | 0.80142 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_36667 | 84 | 1.75 | Mlig455_016177 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.440 Region-enriched R2: 4.490/0.00556 |
6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_016177 {REF} {Length: 3035} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=47.6]; Immunoglobulin domain [PF13927.8, score=47.0]; Immunoglobulin domain [PF00047.27, score=32.1]; Immunoglobulin domain [PF13895.8, score=27.4]; Natural killer cell receptor 2B4 [PF11465.10, score=26.4]; Immunoglobulin V-set domain [PF07686.19, score=23.5]} {Dmel: FBgn0259245, DIP-beta, Dpr-interacting protein beta, [Score=58.9, Expect=3e-09]} {Celegans: WBGene00006985, zig-8, Zwei Ig domain protein zig-8, [RH, Score=57.0, Expect=4e-09]} {Smed: dd_Smed_v6_21969_0_1, dd_Smed_v6_21969_0_1, [Score=72.0, Expect=6e-14]} {RNA1509_49618} {RNA1310_15195} {RNA815_58259} | |
2. | MligTC455_04162 | 131 | 2.73 | Mlig455_028924 | Neo: - |
HMCN1 | 4.31 | 0.957 | 0.705 | - | 0.970 | 0.823 | 0.855 | Mlig455_028924 {REF} {Length: 3929} {Pfam: Immunoglobulin domain [PF13927.8, score=144.9]; Immunoglobulin I-set domain [PF07679.18, score=119.8]; Immunoglobulin domain [PF13895.8, score=113.4]; Immunoglobulin domain [PF00047.27, score=102.3]; Immunoglobulin V-set domain [PF07686.19, score=36.7]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=35.3]; Immunoglobulin C1-set domain [PF07654.17, score=23.3]; C17orf99 Ig domain [PF17736.3, score=20.9]; Immunoglobulin domain [PF18452.3, score=19.8]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=103, Expect=2e-21]; ENSG00000148357, HMCN2, hemicentin 2, [Score=100, Expect=8e-21]} {Mouse: ENSMUSG00000051747, Ttn, titin, [Score=107, Expect=5e-23]; ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=103, Expect=7e-22]} {Dmel: FBgn0000547, ed, echinoid, [Score=147, Expect=2e-35]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=100, Expect=3e-21]} {Smed: dd_Smed_v6_13903_0_1, dd_Smed_v6_13903_0_1, [Score=162, Expect=2e-40]} {RNA1310_26618} {RNA815_41641} |
3. | MligTC455_18506 | 59 | 1.23 | Mlig455_038054 | Neo: - Age: Down-Up-Down |
SP9 | 4.218 | 0.958 | 0.770 | - | 0.857 | 0.784 | 0.849 | Mlig455_038054 {REF} {Length: 3168} {Pfam: Zinc-finger double domain [PF13465.8, score=49.0]; Zinc finger, C2H2 type [PF00096.28, score=40.9]; C2H2-type zinc finger [PF13894.8, score=26.8]} {Human: ENSG00000217236, SP9, Sp9 transcription factor, [RH, Score=202, Expect=4e-59]; ENSG00000164651, SP8, Sp8 transcription factor, [RH, Score=202, Expect=5e-59]} {Mouse: ENSMUSG00000068859, Sp9, trans-acting transcription factor 9, [RH, Score=202, Expect=3e-59]; ENSMUSG00000048562, Sp8, trans-acting transcription factor 8, [RH, Score=201, Expect=9e-59]} {Dmel: FBgn0020378, Sp1, [RH, Score=198, Expect=6e-56]} {Celegans: WBGene00012735, sptf-3, SP (Specificity Protein) Transcription Factor, [Score=137, Expect=1e-35]} {Smed: dd_Smed_v6_17385_0_1, dd_Smed_v6_17385_0_1, [RH, Score=160, Expect=5e-46]} {RNA1310_42373} |
4. | MligTC455_34707 | 705 | 14.69 | Mlig455_047562, Mlig455_047574 | Neo: - Age: - Region-enriched R8: 2.979/0.00000 Regeneration-downregulated TP: -3.783 Regeneration-depleted TP: -3.783 |
ABCA1 | 3.635 | - | - | 0.887 | 0.909 | 0.979 | 0.860 | Mlig455_047562 {REF} {Length: 7841} {Human: ENSG00000165029, ABCA1, ATP binding cassette subfamily A member 1, [Score=149, Expect=9e-40]; ENSG00000198691, ABCA4, ATP binding cassette subfamily A member 4, [Score=144, Expect=6e-38]} {Mouse: ENSMUSG00000015243, Abca1, ATP-binding cassette, sub-family A (ABC1), member 1, [Score=150, Expect=2e-40]} {Dmel: FBgn0031170, CG1718, [Score=150, Expect=1e-40]} {Celegans: WBGene00000022, abt-4, ABC Transporter family, [Score=122, Expect=5e-31]} {Smed: dd_Smed_v6_10304_0_1, dd_Smed_v6_10304_0_1, [Score=124, Expect=1e-31]} {RNA1509_2597} {RNA1310_287.1} {RNA815_111} Mlig455_047574 {REF} {Length: 7925} {Pfam: ABC transporter [PF00005.29, score=177.3]; ABC-2 family transporter protein [PF12698.9, score=155.4]; AAA domain, putative AbiEii toxin, Type IV TA system [PF13304.8, score=69.7]; Domain of unknown function (DUF4162) [PF13732.8, score=26.2]} {Human: ENSG00000165029, ABCA1, ATP binding cassette subfamily A member 1, [Score=1091, Expect=0.0]} {Mouse: ENSMUSG00000015243, Abca1, ATP-binding cassette, sub-family A (ABC1), member 1, [Score=1088, Expect=0.0]} {Dmel: FBgn0031170, CG1718, [Score=442, Expect=1e-128]} {Celegans: WBGene00000022, abt-4, ABC Transporter family, [Score=357, Expect=5e-100]} {Smed: dd_Smed_v6_2300_0_7, dd_Smed_v6_2300_0_7, [RH, Score=1004, Expect=0.0]} {RNA1509_2597, RNA1509_28410} {RNA1310_287.1, RNA1509_28410} {RNA1509_28410, RNA815_111} |
5. | MligTC455_46052 | 159 | 3.31 | Mlig455_020714 | Neo: - Age: - Region-enriched R2: 2.603/0.01508 |
TRAF5 | 3.626 | 0.975 | - | - | 0.922 | 0.924 | 0.805 | Mlig455_020714 {REF} {Length: 919} {Human: ENSG00000082512, TRAF5, TNF receptor associated factor 5, [Score=90.5, Expect=3e-20]} {Mouse: ENSMUSG00000111385, Traf5, TNF receptor-associated factor 5, [Score=88.2, Expect=1e-20]; ENSMUSG00000026637, Traf5, TNF receptor-associated factor 5, [Score=88.2, Expect=1e-20]} {Dmel: FBgn0026319, Traf4, TNF-receptor-associated factor 4, [Score=73.6, Expect=8e-15]} {Celegans: WBGene00006612, trf-1, TNF Receptor Associated Factor (TRAF) homolog; TRF-1, [Score=98.6, Expect=1e-23]} {Smed: dd_Smed_v6_13517_0_1, dd_Smed_v6_13517_0_1, [Score=135, Expect=1e-36]} {RNA1310_36792.1} {RNA815_40908} |
6. | MligTC455_44120 | 125 | 2.61 | Mlig455_041513 | Neo: - Age: Up-Down-Down Region-enriched R2: 7.169/0.00020 |
3.558 | 0.969 | - | - | 0.859 | 0.854 | 0.876 | Mlig455_041513 {REF} {Length: 644} {NoTransDecoderORF} {RNA1310_39164} {RNA815_4344} | |
7. | MligTC455_14130 | 101 | 2.11 | Mlig455_028802 | Neo: - Age: - Region-enriched R7: 4.171/0.00325 |
3.532 | - | - | 0.886 | 0.819 | 0.959 | 0.868 | Mlig455_028802 {REF} {Length: 1282} {Pfam: Lectin C-type domain [PF00059.23, score=21.4]} {RNA1509_20946} {RNA1310_33562} {RNA815_30982} | |
8. | MligTC455_37786 | 1733 | 36.1 | Mlig455_019324, Mlig455_019438, Mlig455_019545 | Neo: - |
3.518 | 0.970 | - | - | 0.934 | 0.768 | 0.846 | Mlig455_019324 {REF} {Length: 3964} {Pfam: FAM216B protein family [PF15107.8, score=19.0]} {RNA1509_21362, RNA1509_30523} {RNA1310_10336.1, RNA1509_30523} {RNA1509_30523, RNA815_4271} Mlig455_019438 {REF} {Length: 1903} {Pfam: FAM216B protein family [PF15107.8, score=19.0]} {RNA1509_21362} {RNA1310_10336.1, RNA1509_21362} {RNA1509_21362, RNA815_4271} Mlig455_019545 {REF} {Length: 3361} {Pfam: FAM216B protein family [PF15107.8, score=18.9]} {RNA1509_21362} {RNA1310_10336.1} {RNA815_4271} |
|
9. | MligTC455_29051 | 484 | 10.08 | Mlig455_064767 | Neo: - Age: - |
TMEM30A | 3.515 | 0.951 | - | - | 0.922 | 0.904 | 0.738 | Mlig455_064767 {REF} {Length: 2581} {TRANSSPLICED} {Pfam: LEM3 (ligand-effect modulator 3) family / CDC50 family [PF03381.17, score=265.5]} {Human: ENSG00000112697, TMEM30A, transmembrane protein 30A, [RH, Score=234, Expect=7e-73]} {Mouse: ENSMUSG00000032328, Tmem30a, transmembrane protein 30A, [RH, Score=241, Expect=6e-76]} {Dmel: FBgn0030752, CG9947, [RH, Score=294, Expect=8e-97]} {Celegans: WBGene00019946, chat-1, CDC50 family protein chat-1, [Score=246, Expect=3e-78]} {Smed: dd_Smed_v6_6430_0_1, dd_Smed_v6_6430_0_1, [Score=274, Expect=3e-89]} {RNA1509_38539, RNA1509_38955} {RNA1310_9371, RNA1509_38539, RNA1509_38955} {RNA1509_38539, RNA1509_38955, RNA815_12157} |
10. | MligTC455_24270 | 71 | 1.47 | Mlig455_005120 | Neo: - Age: - |
CHRNA7 | 3.496 | - | 0.812 | - | 0.897 | 0.950 | 0.837 | Mlig455_005120 {REF} {Length: 1530} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=115.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=66.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=148, Expect=4e-39]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=147, Expect=5e-39]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=145, Expect=4e-38]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=146, Expect=2e-38]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=140, Expect=1e-36]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=135, Expect=5e-34]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=134, Expect=9e-35]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=133, Expect=4e-34]} {RNA1509_43533} {RNA1310_20839.2} {RNA815_22406} |
11. | MligTC455_40610 | 165 | 3.43 | Mlig455_064484 | Neo: - Age: - Region-enriched R2: 5.617/0.00105 |
3.438 | 0.974 | - | - | 0.802 | 0.818 | 0.844 | Mlig455_064484 {REF} {Length: 2931} {Pfam: Sushi repeat (SCR repeat) [PF00084.22, score=24.9]} {Smed: dd_Smed_v6_41498_0_1, dd_Smed_v6_41498_0_1, [Score=154, Expect=2e-40]} {RNA1509_26568} {RNA1310_9342.1, RNA1509_26568} {RNA1509_26568, RNA815_7018} | |
12. | MligTC455_19908 | 490 | 10.21 | Mlig455_047266, Mlig455_047318, Mlig455_069346 | Neo: - Age: logFC(26M/2M)=0.566 |
3.425 | - | 0.771 | - | 0.846 | 0.970 | 0.838 | Mlig455_047266 {REF} {Length: 1728} {Pfam: Glycine rich protein [PF12810.9, score=49.4]} {RNA1509_28009} {RNA1310_17226} {RNA815_32720} Mlig455_047318 {REF} {Length: 2268} {Pfam: Glycine rich protein [PF12810.9, score=36.7]} {RNA1509_28009} {RNA1310_17226, RNA1509_28009} {RNA1509_28009, RNA815_32720} Mlig455_069346 {REF} {Length: 1953} {Pfam: Glycine rich protein [PF12810.9, score=31.6]} {RNA1509_28009} {RNA1310_17226} {RNA815_32720} |
|
13. | MligTC455_03228 | 275 | 5.73 | Mlig455_035802 | Neo: - Age: - Region-enriched R2: 2.387/0.02287 |
KCNN2 | 3.406 | 0.835 | - | - | 0.852 | 0.956 | 0.763 | Mlig455_035802 {REF} {Length: 3854} {Pfam: Calcium-activated SK potassium channel [PF03530.16, score=141.7]; Calmodulin binding domain [PF02888.18, score=74.3]; Ion channel [PF07885.18, score=58.4]} {Human: ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [Score=398, Expect=1e-133]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [Score=396, Expect=8e-131]; ENSG00000105642, KCNN1, potassium calcium-activated channel subfamily N member 1, [Score=395, Expect=9e-133]} {Mouse: ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [Score=399, Expect=6e-131]; ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [Score=397, Expect=2e-131]; ENSMUSG00000002908, Kcnn1, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1, [Score=387, Expect=4e-130]; ENSMUSG00000111706, Kcnn1, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1, [Score=387, Expect=4e-130]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [Score=422, Expect=5e-144]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [Score=333, Expect=5e-108]} {Smed: dd_Smed_v6_13309_0_1, dd_Smed_v6_13309_0_1, [RH, Score=481, Expect=6e-168]} {RNA1509_42110} {RNA1310_18606.1, RNA1509_42110} {RNA1509_42110, RNA815_13732} |
14. | MligTC455_30540 | 1159 | 24.14 | Mlig455_048840 | Neo: - |
3.4 | 0.903 | - | - | 0.799 | 0.972 | 0.726 | Mlig455_048840 {REF} {Length: 3299} {TRANSSPLICED} {Smed: dd_Smed_v6_6429_0_1, dd_Smed_v6_6429_0_1, [RH, Score=123, Expect=2e-30]} {RNA1509_3399} {RNA1310_7154.1} {RNA815_2838.1} | |
15. | MligTC455_03227 | 266 | 5.54 | Mlig455_035719 | Neo: - Age: - Region-enriched R2: 2.342/0.02665 |
3.387 | 0.835 | - | - | 0.852 | 0.959 | 0.741 | Mlig455_035719 {REF} {Length: 154} {NoTransDecoderORF} {RNA1310_97182} {RNA815_18537} | |
16. | MligTC455_15679 | 88 | 1.82 | Mlig455_057219 | Neo: - Age: Down-Up-Up |
WSCD2 | 3.363 | 0.979 | - | - | 0.744 | 0.792 | 0.848 | Mlig455_057219 {REF} {Length: 1035} {Pfam: WSC domain [PF01822.21, score=55.1]; PAN domain [PF00024.28, score=27.0]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=52.8, Expect=2e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=51.6, Expect=3e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=53.5, Expect=5e-08]} {RNA1509_46267} {RNA1310_46146} {RNA815_32275.1} |
17. | MligTC455_21353 | 452 | 9.41 | Mlig455_004209, Mlig455_004221 | Neo: - |
3.353 | 0.968 | - | - | 0.711 | 0.844 | 0.830 | Mlig455_004209 {REF} {Length: 1786} {Smed: dd_Smed_v6_11196_0_1, dd_Smed_v6_11196_0_1, [RH, Score=100, Expect=1e-24]} {RNA1509_45598} {RNA1310_22701, RNA1509_45598} {RNA1509_45598, RNA815_19949} Mlig455_004221 {REF} {Length: 1440} {Smed: dd_Smed_v6_11196_0_1, dd_Smed_v6_11196_0_1, [Score=84.0, Expect=9e-19]} {RNA1509_45598} {RNA1310_32084} {RNA815_19949} |
|
18. | MligTC455_21635 | 1157 | 24.11 | Mlig455_026396 | Neo: - Age: - |
SLC6A5 | 3.345 | - | 0.704 | - | 0.925 | 0.963 | 0.753 | Mlig455_026396 {REF} {Length: 3636} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=612.2]} {Human: ENSG00000165970, SLC6A5, solute carrier family 6 member 5, [Score=486, Expect=2e-161]} {Mouse: ENSMUSG00000039728, Slc6a5, solute carrier family 6 (neurotransmitter transporter, glycine), member 5, [Score=490, Expect=6e-163]} {Dmel: FBgn0034911, CG5549, [Score=499, Expect=2e-162]} {Celegans: WBGene00004905, snf-6, Sodium-dependent acetylcholine transporter, [RH, Score=374, Expect=2e-119]} {Smed: dd_Smed_v6_10458_0_1, dd_Smed_v6_10458_0_1, [Score=459, Expect=1e-152]} {RNA1509_26562} {RNA1310_4707.2, RNA1509_26562} {RNA1509_26562, RNA815_1349.2} |
19. | MligTC455_52325 | 682 | 14.2 | Mlig455_061124 | Neo: - Age: logFC(26M/2M)=-0.271 Regeneration-downregulated BL: -1.826 Regeneration-depleted BL: -1.826 |
3.339 | 0.850 | - | - | 0.801 | 0.967 | 0.721 | Mlig455_061124 {REF} {Length: 9447} {Pfam: Fibrinogen binding protein [PF08017.13, score=176.9]} {RNA1509_13352, RNA1509_42393, RNA1509_55215, RNA1509_58455} {RNA1310_7913, RNA1509_13352, RNA1509_42393, RNA1509_55215, RNA1509_58455} {RNA1509_13352, RNA1509_42393, RNA1509_55215, RNA1509_58455, RNA815_2288} | |
20. | MligTC455_29030 | 141 | 2.93 | Mlig455_061986 | Neo: - Age: logFC(26M/2M)=-0.349 Region-enriched R2: 5.117/0.03372 |
FZD5 | 3.222 | 0.981 | - | - | 0.714 | 0.735 | 0.792 | Mlig455_061986 {REF} {Length: 3701} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=386.1]; Fz domain [PF01392.24, score=95.9]} {Human: ENSG00000163251, FZD5, frizzled class receptor 5, [Score=582, Expect=0.0]} {Mouse: ENSMUSG00000045005, Fzd5, frizzled class receptor 5, [RH, Score=586, Expect=0.0]} {Dmel: FBgn0016797, fz2, frizzled 2, [Score=545, Expect=0.0]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=388, Expect=7e-127]} {Smed: dd_Smed_v6_16571_0_1, dd_Smed_v6_16571_0_1, [RH, Score=556, Expect=0.0]} {RNA1509_35313} {RNA1310_9623.1} {RNA815_2562.1} |
21. | MligTC455_36609 | 196 | 4.08 | Mlig455_018538 | Neo: - Age: - |
ANKRD18B | 3.21 | 0.955 | - | - | 0.759 | 0.732 | 0.764 | Mlig455_018538 {REF} {Length: 4748} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=80.9]; Ankyrin repeats (many copies) [PF13637.8, score=66.0]; Ankyrin repeat [PF00023.32, score=58.7]; Ankyrin repeats (many copies) [PF13857.8, score=55.5]; Ankyrin repeat [PF13606.8, score=52.9]} {Human: ENSG00000230453, ANKRD18B, ankyrin repeat domain 18B, [RH, Score=105, Expect=4e-22]} {Mouse: ENSMUSG00000022246, Rai14, retinoic acid induced 14, [Score=100, Expect=8e-21]; ENSMUSG00000020481, Ankrd36, ankyrin repeat domain 36, [Score=96.3, Expect=2e-19]; ENSMUSG00000029517, Ankrd7, ankyrin repeat domain 7, [Score=95.9, Expect=5e-21]} {Dmel: FBgn0037759, CG8526, [Score=68.9, Expect=2e-11]} {Celegans: WBGene00004053, tank-1, Tankyrase-like protein, [Score=72.0, Expect=3e-12]} {Smed: dd_Smed_v6_7813_0_1, dd_Smed_v6_7813_0_1, [Score=82.4, Expect=6e-16]} {RNA1509_17141} {RNA1310_571} {RNA815_5717} |
22. | MligTC455_38657 | 292 | 6.08 | Mlig455_021581 | Neo: - Age: - |
CPLX1 | 3.189 | 0.762 | - | - | 0.715 | 0.970 | 0.742 | Mlig455_021581 {REF} {Length: 2085} {Pfam: Synaphin protein [PF05835.14, score=132.9]} {Human: ENSG00000168993, CPLX1, complexin 1, [Score=52.4, Expect=8e-09]; ENSG00000145920, CPLX2, complexin 2, [Score=50.8, Expect=1e-08]} {Mouse: ENSMUSG00000033615, Cplx1, complexin 1, [Score=53.5, Expect=2e-09]} {Dmel: FBgn0041605, cpx, complexin, [RH, Score=90.1, Expect=1e-23]} {Celegans: WBGene00022271, cpx-1, Putative complexin-1, [RH, Score=99.4, Expect=2e-27]} {Smed: dd_Smed_v6_9918_0_1, dd_Smed_v6_9918_0_1, [Score=94.4, Expect=2e-25]} {RNA1509_37151, RNA1509_38047} {RNA1310_51275, RNA1509_38047} {RNA1509_38047, RNA815_22799} |
23. | MligTC455_46584 | 107 | 2.22 | Mlig455_010128 | Neo: - Age: Up-Down-Down |
KCNC2 | 2.809 | 0.969 | - | - | 0.935 | 0.905 | - | Mlig455_010128 {REF} {Length: 1706} {Human: ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=74.3, Expect=3e-15]} {Mouse: ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=74.3, Expect=3e-16]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=114, Expect=3e-29]} {Celegans: WBGene00001202, egl-36, Potassium voltage-gated channel protein egl-36, [Score=100, Expect=1e-24]} {Smed: dd_Smed_v6_17998_0_1, dd_Smed_v6_17998_0_1, [Score=118, Expect=1e-32]} {RNA1310_24374} {RNA815_11270} |
24. | MligTC455_18619 | 527 | 10.97 | Mlig455_030641, Mlig455_030999 | Neo: - Age: - |
COL6A5 | 2.784 | - | - | - | 0.910 | 0.981 | 0.893 | Mlig455_030641 {REF} {Length: 2413} {Pfam: Collagen triple helix repeat (20 copies) [PF01391.20, score=111.9]} {Human: ENSG00000172752, COL6A5, collagen type VI alpha 5 chain, [Score=129, Expect=6e-31]} {Mouse: ENSMUSG00000032572, Col6a4, collagen, type VI, alpha 4, [Score=96.7, Expect=2e-20]; ENSMUSG00000028197, Col24a1, collagen, type XXIV, alpha 1, [Score=95.5, Expect=5e-20]} {Dmel: FBgn0000299, Col4a1, Collagen type IV alpha 1, [Score=91.3, Expect=7e-19]} {Celegans: WBGene00000708, col-135, COLlagen, [Score=99.0, Expect=1e-21]} {Smed: dd_Smed_v6_9565_0_1, dd_Smed_v6_9565_0_1, [Score=111, Expect=2e-25]} {RNA1509_35455} {RNA1310_11079.1} {RNA815_14901} Mlig455_030999 {REF} {Length: 2379} {Pfam: Collagen triple helix repeat (20 copies) [PF01391.20, score=97.0]} {Human: ENSG00000172752, COL6A5, collagen type VI alpha 5 chain, [Score=117, Expect=9e-27]} {Mouse: ENSMUSG00000031502, Col4a1, collagen, type IV, alpha 1, [Score=95.5, Expect=5e-20]; ENSMUSG00000026390, Marco, macrophage receptor with collagenous structure, [Score=91.7, Expect=3e-19]} {Dmel: FBgn0016075, vkg, viking, [Score=83.6, Expect=2e-16]} {Celegans: WBGene00000708, col-135, COLlagen, [Score=90.9, Expect=5e-19]} {Smed: dd_Smed_v6_9565_0_1, dd_Smed_v6_9565_0_1, [Score=105, Expect=1e-23]} {RNA1509_35455} {RNA1310_15043} {RNA815_14901} |
25. | MligTC455_26092 | 67 | 1.39 | Mlig455_048489 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=0.677 Region-enriched R2: 4.303/0.01110 |
2.75 | 0.977 | - | - | - | 0.940 | 0.833 | Mlig455_048489 {REF} {Length: 2319} {Pfam: Lectin C-type domain [PF00059.23, score=23.3]} {RNA1509_25383} {RNA1310_27113} {RNA815_24719} | |
26. | MligTC455_45770 | 227 | 4.74 | Mlig455_059517 | Neo: - Age: Down-Up-Up |
2.745 | - | - | - | 0.970 | 0.973 | 0.802 | Mlig455_059517 {REF} {Length: 3260} {Pfam: NACHT domain [PF05729.14, score=31.8]; AAA ATPase domain [PF13191.8, score=23.9]} {Smed: dd_Smed_v6_9074_0_1, dd_Smed_v6_9074_0_1, [Score=143, Expect=4e-35]} {RNA1509_44893} {RNA1310_38241, RNA1509_44893} {RNA1509_44893, RNA815_33748} | |
27. | MligTC455_54337 | 46 | 0.96 | Mlig455_000362 | Neo: - |
PKDREJ | 2.735 | 0.981 | - | - | 0.819 | 0.935 | - | Mlig455_000362 {REF} {Length: 11405} {Pfam: Polycystin cation channel [PF08016.14, score=291.7]; PLAT/LH2 domain [PF01477.25, score=67.3]; Ion transport protein [PF00520.33, score=42.2]; GPCR proteolysis site, GPS, motif [PF01825.23, score=27.7]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [Score=274, Expect=2e-73]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=306, Expect=2e-83]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=152, Expect=6e-37]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=291, Expect=4e-79]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=1425, Expect=0.0]} {RNA1509_16432} {RNA1310_1236, RNA1509_16432} {RNA1509_16432, RNA815_2411} |
28. | MligTC455_42037 | 1931 | 40.23 | Mlig455_063391 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.444 Region-specific R2: 2.479 Region-enriched R2: 1.442/0.00136 |
2.732 | - | - | - | 0.877 | 0.974 | 0.881 | Mlig455_063391 {REF} {Length: 1482} {RNA1509_22218, RNA1509_26529, RNA1509_28020, RNA1509_35236} {RNA1310_24553, RNA1509_22218, RNA1509_26529, RNA1509_28020, RNA1509_35236} {RNA1509_22218, RNA1509_26529, RNA1509_28020, RNA1509_35236, RNA815_11766} | |
29. | MligTC455_18787 | 963 | 20.06 | Mlig455_014022 | Neo: - Age: - Region-enriched R2: 1.334/0.03482 |
STRC | 2.725 | - | - | - | 0.885 | 0.967 | 0.873 | Mlig455_014022 {REF} {Length: 5754} {Human: ENSG00000242866, STRC, stereocilin, [RH, Score=76.3, Expect=4e-13]} {Mouse: ENSMUSG00000033498, Strc, stereocilin, [RH, Score=80.9, Expect=1e-14]} {RNA1509_4378} {RNA1310_1493.1, RNA1509_4378} {RNA1509_4378, RNA815_804} |
30. | MligTC455_33832 | 112 | 2.34 | Mlig455_029411 | Neo: - Age: Up-Down-Down Region-enriched R2: 5.300/0.00016 |
GLRA3 | 2.725 | - | - | - | 0.954 | 0.959 | 0.812 | Mlig455_029411 {REF} {Length: 3686} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=84.5]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=257, Expect=5e-80]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=253, Expect=3e-78]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=250, Expect=4e-77]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=251, Expect=2e-77]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=249, Expect=5e-77]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=248, Expect=2e-76]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=243, Expect=1e-74]} {Dmel: FBgn0024963, GluClalpha, [Score=253, Expect=2e-78]} {Celegans: WBGene00000233, avr-15, GluClalpha2B protein, [Score=259, Expect=7e-81]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [RH, Score=480, Expect=1e-167]} {RNA1509_35986} {RNA1310_35528} {RNA815_35433} |
31. | MligTC455_19278 | 4335 | 90.31 | Mlig455_057304, Mlig455_070944 | Neo: - Age: logFC(26M/2M)=0.686 Region-specific R2: 5.590 Region-enriched R2: 5.465/0.00000 |
CHRNA10 | 2.724 | - | - | - | 0.908 | 0.952 | 0.864 | Mlig455_057304 {REF} {Length: 1001} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=71.6]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=77.0, Expect=2e-16]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=75.9, Expect=4e-16]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=75.5, Expect=6e-16]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=73.9, Expect=2e-15]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=93.6, Expect=2e-22]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=100, Expect=5e-25]} {Smed: dd_Smed_v6_11955_0_1, dd_Smed_v6_11955_0_1, [Score=82.8, Expect=8e-19]} {RNA1509_23115} {RNA1310_34970} {RNA815_15305.1} Mlig455_070944 {REF} {Length: 1060} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=88.2]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=95.9, Expect=6e-22]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=96.3, Expect=3e-22]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=94.7, Expect=1e-21]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=112, Expect=7e-28]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=118, Expect=4e-30]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=98.6, Expect=2e-23]} {RNA1509_23115, RNA1509_43907, RNA1509_9432} {RNA1310_34970, RNA1509_23115, RNA1509_43907, RNA1509_9432} {RNA1509_23115, RNA1509_43907, RNA1509_9432, RNA815_15305.1} |
32. | MligTC455_28684 | 179 | 3.74 | Mlig455_027569 | Neo: - Age: Down-Up-Up |
2.718 | 0.959 | - | - | 0.892 | - | 0.867 | Mlig455_027569 {REF} {Length: 1247} {RNA1509_49958} {RNA1310_47608, RNA1509_49958} {RNA1509_49958, RNA815_33601} | |
33. | MligTC455_46394 | 8810 | 183.54 | Mlig455_054818, Mlig455_054826 | Neo: - Age: - Region-specific R2: 1.771 Region-enriched R2: 1.255/0.00038 |
PKD2 | 2.715 | - | - | - | 0.891 | 0.950 | 0.874 | Mlig455_054818 {REF} {Length: 2992} {TRANSSPLICED} {Pfam: Polycystin cation channel [PF08016.14, score=487.7]; Ion transport protein [PF00520.33, score=93.3]; EF hand [PF00036.34, score=32.7]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=21.3]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=750, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=747, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=323, Expect=1e-96]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=380, Expect=6e-120]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [Score=733, Expect=0.0]} {RNA1509_1615} {RNA1310_21296.2, RNA1509_1615} {RNA1509_1615, RNA815_3158.1} Mlig455_054826 {REF} {Length: 3118} {TRANSSPLICED} {Pfam: Polycystin cation channel [PF08016.14, score=487.7]; Ion transport protein [PF00520.33, score=93.4]; EF hand [PF00036.34, score=32.6]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=21.2]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=754, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=751, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=323, Expect=2e-96]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=387, Expect=1e-122]} {Smed: dd_Smed_v6_13327_0_1, dd_Smed_v6_13327_0_1, [RH, Score=769, Expect=0.0]} {RNA1509_13522} {RNA1310_21296.2} {RNA815_3158.1} |
34. | MligTC455_24536 | 120 | 2.5 | Mlig455_028895 | Neo: - Age: Up-Down-Down |
TRPA1 | 2.713 | - | - | - | 0.848 | 0.959 | 0.906 | Mlig455_028895 {REF} {Length: 4399} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=276.9]; Ankyrin repeats (many copies) [PF13637.8, score=235.5]; Ankyrin repeats (many copies) [PF13857.8, score=187.3]; Ankyrin repeat [PF00023.32, score=185.3]; Ankyrin repeat [PF13606.8, score=184.2]; Ion transport protein [PF00520.33, score=31.3]} {Human: ENSG00000104321, TRPA1, transient receptor potential cation channel subfamily A member 1, [Score=295, Expect=6e-83]} {Mouse: ENSMUSG00000032769, Trpa1, transient receptor potential cation channel, subfamily A, member 1, [Score=277, Expect=4e-77]} {Dmel: FBgn0035934, TrpA1, Transient receptor potential cation channel A1, [Score=305, Expect=2e-86]} {Celegans: WBGene00007801, trpa-1, Transient receptor potential cation channel subfamily A member 1 homolog, [Score=276, Expect=1e-76]} {Smed: dd_Smed_v6_20683_0_1, dd_Smed_v6_20683_0_1, [RH, Score=551, Expect=2e-178]} {RNA1509_56559} {RNA1310_3837.1} {RNA815_4441} |
35. | MligTC455_38543 | 146 | 3.03 | Mlig455_017595 | Neo: - Age: - Region-enriched R3: 2.925/0.03259 |
2.712 | 0.960 | - | - | 0.971 | 0.781 | - | Mlig455_017595 {REF} {Length: 1878} {RNA1310_40211} {RNA815_8698} | |
36. | MligTC455_47080 | 362 | 7.54 | Mlig455_037356 | Neo: - Age: - Region-enriched R2: 2.691/0.00566 |
SSUH2 | 2.707 | - | - | - | 0.893 | 0.961 | 0.853 | Mlig455_037356 {REF} {Length: 1984} {Pfam: DnaJ central domain [PF00684.21, score=20.9]} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=189, Expect=3e-56]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=156, Expect=5e-44]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=90.9, Expect=7e-20]} {RNA1509_29510} {RNA1310_15488, RNA1509_29510} {RNA1509_29510, RNA815_5650} |
37. | MligTC455_19276 | 1694 | 35.28 | Mlig455_057303 | Neo: - Age: Down-Down-Up Region-specific R2: 5.711 Region-enriched R2: 6.117/0.00000 |
2.706 | - | - | - | 0.887 | 0.953 | 0.866 | Mlig455_057303 {REF} {Length: 1196} {Pfam: TATA-binding related factor (TRF) of subunit 20 of Mediator complex [PF08612.13, score=80.6]} {Smed: dd_Smed_v6_9879_0_1, dd_Smed_v6_9879_0_1, [RH, Score=73.9, Expect=1e-15]} {RNA1509_58478} {RNA1310_35292} {RNA815_20171} | |
38. | MligTC455_49877 | 188 | 3.91 | Mlig455_027465 | Neo: - Age: - Region-enriched R2: 3.005/0.04141 |
AC254952.1 | 2.705 | - | - | - | 0.973 | 0.889 | 0.843 | Mlig455_027465 {REF} {Length: 2059} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=89.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=80.0]} {Human: ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=145, Expect=6e-38]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=144, Expect=1e-37]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=144, Expect=1e-37]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=144, Expect=9e-38]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=141, Expect=2e-36]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=141, Expect=1e-36]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=141, Expect=6e-37]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=139, Expect=5e-36]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=134, Expect=2e-34]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=132, Expect=4e-33]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=126, Expect=6e-32]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=131, Expect=2e-33]} {RNA1310_26175} {RNA815_7952} |
39. | MligTC455_23544 | 169 | 3.53 | Mlig455_021925 | Neo: - Age: Up-Down-Down Region-enriched R2: 3.394/0.00033 |
DDR2 | 2.702 | - | - | - | 0.915 | 0.952 | 0.835 | Mlig455_021925 {REF} {Length: 4813} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=205.5]; Protein kinase domain [PF00069.27, score=103.7]; F5/8 type C domain [PF00754.27, score=57.5]} {Human: ENSG00000162733, DDR2, discoidin domain receptor tyrosine kinase 2, [Score=249, Expect=1e-68]} {Mouse: ENSMUSG00000026674, Ddr2, discoidin domain receptor family, member 2, [Score=251, Expect=1e-69]} {Dmel: FBgn0053531, Ddr, Discoidin domain receptor, [Score=238, Expect=3e-64]} {Celegans: WBGene00017381, svh-4, Discoidin domain-containing receptor tyrosine kinase B, [Score=176, Expect=3e-45]} {Smed: dd_Smed_v6_22332_0_1, dd_Smed_v6_22332_0_1, [Score=187, Expect=2e-48]} {RNA1509_46581} {RNA1310_21361} {RNA815_21661} |
40. | MligTC455_53414 | 331 | 6.9 | Mlig455_053442 | Neo: - Age: - Region-specific R2: 4.308 Region-enriched R2: 3.374/0.00040 |
RP1 | 2.701 | - | - | - | 0.957 | 0.874 | 0.870 | Mlig455_053442 {REF} {Length: 1156} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.8]; Doublecortin [PF03607.19, score=103.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.0]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=473, Expect=5e-146]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=454, Expect=1e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.5, Expect=2e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=698, Expect=0.0]} {RNA1509_21828} {RNA1310_33070.1} {RNA815_13802.1} |
41. | MligTC455_53415 | 319 | 6.64 | Mlig455_053444 | Neo: - Age: Up-Down-Down Region-specific R2: 4.862 Region-enriched R2: 4.179/0.00011 |
RP1 | 2.7 | - | - | - | 0.958 | 0.872 | 0.870 | Mlig455_053444 {REF} {Length: 4944} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.3]; Doublecortin [PF03607.19, score=100.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.5]; Fibroblast growth factor [PF00167.20, score=18.6]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=471, Expect=6e-145]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=453, Expect=3e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.9, Expect=1e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=691, Expect=0.0]} {RNA1509_59703} {RNA1310_2710} {RNA815_17469} |
42. | MligTC455_41396 | 187 | 3.9 | Mlig455_012937, Mlig455_031470 | Neo: - Age: - Region-enriched R2: 4.167/0.01146 |
2.696 | - | - | - | 0.854 | 0.970 | 0.872 | Mlig455_012937 {REF} {Length: 1911} {Smed: dd_Smed_v6_11196_0_1, dd_Smed_v6_11196_0_1, [Score=46.6, Expect=1e-06]} {RNA1509_16138} {RNA1310_24329} {RNA815_11818} Mlig455_031470 {REF} {Length: 1745} {Dmel: FBgn0083971, CG34135, [RH, Score=60.1, Expect=1e-10]} {Smed: dd_Smed_v6_11196_0_1, dd_Smed_v6_11196_0_1, [RH, Score=96.3, Expect=3e-23]} {RNA1509_16138} {RNA1310_24329} {RNA815_11818} |
|
43. | MligTC455_51478 | 66 | 1.37 | Mlig455_057080 | Neo: - Age: - |
2.691 | - | - | - | 0.908 | 0.975 | 0.808 | Mlig455_057080 {REF} {Length: 1661} {Pfam: 7tm Chemosensory receptor [PF08395.14, score=33.2]; Trehalose receptor [PF06151.15, score=30.3]} {RNA1310_59684} {RNA815_43381} | |
44. | MligTC455_23584 | 574 | 11.95 | Mlig455_050813 | Neo: - |
CCDC33 | 2.688 | 0.962 | - | - | 0.804 | 0.922 | - | Mlig455_050813 {REF} {Length: 3399} {TRANSSPLICED} {Pfam: C2 domain [PF00168.32, score=24.3]; C-terminal membrane-localisation domain of ion-channel, VCN1 [PF16799.7, score=19.4]} {Human: ENSG00000140481, CCDC33, coiled-coil domain containing 33, [RH, Score=94.4, Expect=4e-19]} {Mouse: ENSMUSG00000037716, Ccdc33, coiled-coil domain containing 33, [Score=145, Expect=4e-35]} {Smed: dd_Smed_v6_15844_0_1, dd_Smed_v6_15844_0_1, [RH, Score=191, Expect=6e-50]} {RNA1509_7141} {RNA1310_15581.1} {RNA815_780.1} |
45. | MligTC455_38368 | 107 | 2.24 | Mlig455_026435, Mlig455_044757 | Neo: - Age: Up-Down-Down |
SSUH2 | 2.683 | - | - | - | 0.867 | 0.975 | 0.841 | Mlig455_026435 {REF} {Length: 1789} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [RH, Score=233, Expect=1e-72]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [RH, Score=195, Expect=1e-58]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=117, Expect=3e-29]} {RNA1509_6425} {RNA1310_32434} {RNA815_16161} Mlig455_044757 {REF} {Length: 883} {TRANSSPLICED} {RNA1509_28356} {RNA1310_61125} {RNA815_53103} |
46. | MligTC455_25517 | 301 | 6.28 | Mlig455_036413 | Neo: - Age: Up-Down-Up |
2.676 | 0.961 | - | - | - | 0.866 | 0.849 | Mlig455_036413 {REF} {Length: 1873} {RNA1509_52708} {RNA1310_4011} {RNA815_18281.1} | |
47. | MligTC455_05889 | 28 | 0.58 | Mlig455_027604, Mlig455_047689, Mlig455_047690 | Neo: - Age: - |
TLR4 | 2.67 | - | - | - | 0.853 | 0.964 | 0.853 | Mlig455_027604 {REF} {Length: 3445} {Pfam: Leucine rich repeat [PF13855.8, score=68.9]; Leucine Rich repeats (2 copies) [PF12799.9, score=38.2]; TIR domain [PF01582.22, score=31.9]; TIR domain [PF13676.8, score=24.5]; BspA type Leucine rich repeat region (6 copies) [PF13306.8, score=21.4]} {Human: ENSG00000136869, TLR4, toll like receptor 4, [RH, Score=74.3, Expect=6e-13]} {Mouse: ENSMUSG00000031558, Slit2, slit guidance ligand 2, [Score=60.1, Expect=1e-08]; ENSMUSG00000030600, Lrfn1, leucine rich repeat and fibronectin type III domain containing 1, [Score=59.3, Expect=2e-08]; ENSMUSG00000056427, Slit3, slit guidance ligand 3, [Score=58.5, Expect=4e-08]} {Dmel: FBgn0036494, Toll-6, [Score=80.5, Expect=4e-15]} {Celegans: WBGene00006593, tol-1, TOLl (Drosophila) family, [Score=50.4, Expect=6e-06]} {RNA1310_7084} {RNA815_22808} Mlig455_047689 {REF} {Length: 352} {Pfam: Leucine rich repeat [PF13855.8, score=35.5]; Leucine Rich repeats (2 copies) [PF12799.9, score=20.6]} {RNA1310_7084} {RNA815_47088} Mlig455_047690 {REF} {Length: 346} {Pfam: Leucine rich repeat [PF13855.8, score=68.9]; Leucine Rich repeats (2 copies) [PF12799.9, score=38.2]; TIR domain [PF01582.22, score=31.9]; TIR domain [PF13676.8, score=24.5]; BspA type Leucine rich repeat region (6 copies) [PF13306.8, score=21.4]} {Human: ENSG00000136869, TLR4, toll like receptor 4, [RH, Score=74.3, Expect=6e-13]} {Mouse: ENSMUSG00000031558, Slit2, slit guidance ligand 2, [Score=60.1, Expect=1e-08]; ENSMUSG00000030600, Lrfn1, leucine rich repeat and fibronectin type III domain containing 1, [Score=59.3, Expect=2e-08]; ENSMUSG00000056427, Slit3, slit guidance ligand 3, [Score=58.5, Expect=4e-08]} {Dmel: FBgn0036494, Toll-6, [Score=80.5, Expect=4e-15]} {Celegans: WBGene00006593, tol-1, TOLl (Drosophila) family, [Score=50.4, Expect=6e-06]} {RNA1310_7084} {RNA815_47699} |
48. | MligTC455_40654 | 676 | 14.08 | Mlig455_056785 | Neo: - Age: logFC(26M/2M)=-0.402 |
CCDC63 | 2.665 | - | - | - | 0.854 | 0.970 | 0.841 | Mlig455_056785 {REF} {Length: 2093} {TRANSSPLICED} {Pfam: Initiation control protein YabA [PF06156.15, score=20.5]} {Human: ENSG00000173093, CCDC63, coiled-coil domain containing 63, [RH, Score=190, Expect=9e-53]} {Mouse: ENSMUSG00000043036, Ccdc63, coiled-coil domain containing 63, [RH, Score=179, Expect=7e-49]} {Dmel: FBgn0038452, CG14905, [RH, Score=168, Expect=6e-46]} {Smed: dd_Smed_v6_4191_0_1, dd_Smed_v6_4191_0_1, [RH, Score=442, Expect=7e-150]} {RNA1509_17628} {RNA1310_12386, RNA1509_17628} {RNA1509_17628, RNA815_7054} |
49. | MligTC455_50927 | 254 | 5.29 | Mlig455_070541, Mlig455_070562 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.296 Region-enriched R2: 7.883/0.00008 |
FZD4 | 2.663 | - | - | - | 0.863 | 0.956 | 0.844 | Mlig455_070541 {REF} {Length: 3522} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=471, Expect=6e-159]} {RNA1509_15834} {RNA1310_3800, RNA1509_15834} {RNA1509_15834, RNA815_19571} Mlig455_070562 {REF} {Length: 3527} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=2e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=470, Expect=8e-159]} {RNA1509_15834} {RNA1310_3800} {RNA815_19571} |
50. | MligTC455_16908 | 161 | 3.35 | Mlig455_046916 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.397 Region-enriched R2: 2.938/0.02849 |
SLC17A6 | 2.66 | - | - | - | 0.822 | 0.976 | 0.862 | Mlig455_046916 {REF} {Length: 3198} {Pfam: Major Facilitator Superfamily [PF07690.18, score=172.0]; Uncharacterised MFS-type transporter YbfB [PF06779.16, score=19.6]} {Human: ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [RH, Score=548, Expect=0.0]; ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [RH, Score=542, Expect=0.0]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [RH, Score=536, Expect=0.0]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [RH, Score=551, Expect=0.0]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [RH, Score=547, Expect=0.0]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [RH, Score=543, Expect=0.0]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=482, Expect=6e-163]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [RH, Score=479, Expect=7e-163]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [RH, Score=591, Expect=0.0]} {RNA1509_38152} {RNA1310_23072, RNA1509_38152} {RNA1509_38152, RNA815_14894} |
51. | MligTC455_53843 | 1448 | 30.17 | Mlig455_048664 | Neo: - Age: logFC(26M/2M)=0.488 |
2.657 | - | - | - | 0.821 | 0.978 | 0.858 | Mlig455_048664 {REF} {Length: 1660} {RNA1509_15580} {RNA1310_24090, RNA1509_15580} {RNA1509_15580, RNA815_10676.2} | |
52. | MligTC455_31164 | 572 | 11.91 | Mlig455_029609, Mlig455_045673 | Neo: - Age: - |
2.654 | - | - | - | 0.846 | 0.958 | 0.850 | Mlig455_029609 {REF} {Length: 746} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=39.4]} {Smed: dd_Smed_v6_22533_0_1, dd_Smed_v6_22533_0_1, [Score=48.5, Expect=1e-06]} {RNA1310_96354} {RNA815_44390} Mlig455_045673 {REF} {Length: 2025} {RNA1509_21720} {RNA1310_14760} {RNA815_24583} |
|
53. | MligTC455_39956 | 118 | 2.47 | Mlig455_038145 | Neo: - Age: - Region-enriched R2: 5.450/0.00015 |
ADGB | 2.652 | 0.809 | - | - | - | 0.983 | 0.860 | Mlig455_038145 {REF} {Length: 7557} {tRNA: Ile(TAT),pseudo, score=35.9} {Pfam: Calpain family cysteine protease [PF00648.23, score=31.4]} {Human: ENSG00000118492, ADGB, androglobin, [Score=431, Expect=4e-124]} {Mouse: ENSMUSG00000050994, Adgb, androglobin, [Score=255, Expect=7e-68]} {Celegans: WBGene00000543, clp-2, CaLPain family, [Score=73.2, Expect=1e-12]} {Smed: dd_Smed_v6_10677_0_1, dd_Smed_v6_10677_0_1, [Score=248, Expect=2e-66]} {RNA1509_15950, RNA1509_36374, RNA1509_49600} {RNA1310_4821, RNA1509_15950, RNA1509_36374, RNA1509_49600} {RNA1509_15950, RNA1509_36374, RNA1509_49600, RNA815_11351} |
54. | MligTC455_41324 | 401 | 8.35 | Mlig455_024997 | Neo: - Age: Up-Down-Down |
CCDC151 | 2.649 | - | - | - | 0.880 | 0.975 | 0.794 | Mlig455_024997 {REF} {Length: 2376} {TRANSSPLICED} {Human: ENSG00000198003, CCDC151, coiled-coil domain containing 151, [Score=251, Expect=5e-75]} {Mouse: ENSMUSG00000039632, Ccdc151, coiled-coil domain containing 151, [Score=261, Expect=4e-79]} {Dmel: FBgn0036219, CCDC151, Coiled-coil domain containing protein 151, [Score=111, Expect=2e-25]} {Smed: dd_Smed_v6_4526_0_1, dd_Smed_v6_4526_0_1, [Score=463, Expect=3e-158]} {RNA1509_18758} {RNA1310_9513.1, RNA1509_18758} {RNA1509_18758, RNA815_13766} |
55. | MligTC455_25516 | 623 | 12.97 | Mlig455_036379, Mlig455_054584 | Neo: - Age: - |
2.643 | 0.960 | - | - | - | 0.866 | 0.817 | Mlig455_036379 {REF} {Length: 3088} {RNA1509_28479, RNA1509_52708} {RNA1310_4011, RNA1509_52708} {RNA1509_52708, RNA815_18281.1} Mlig455_054584 {REF} {Length: 3410} {RNA1509_28479} {RNA1310_4011} {RNA815_18281.1} |
|
56. | MligTC455_53842 | 1222 | 25.46 | Mlig455_023890 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.345 Region-enriched R2: 1.546/0.01667 |
2.641 | - | - | - | 0.827 | 0.954 | 0.860 | Mlig455_023890 {REF} {Length: 1336} {RNA1509_15580} {RNA1310_22487.1} {RNA815_10676.1} | |
57. | MligTC455_49307 | 122 | 2.55 | Mlig455_055230 | Neo: - Age: - Region-enriched R2: 4.447/0.04819 |
ZAN | 2.64 | - | - | - | 0.921 | 0.977 | 0.742 | Mlig455_055230 {REF} {Length: 2947} {Pfam: Glycine rich protein [PF12810.9, score=28.6]} {Human: ENSG00000146839, ZAN, zonadhesin (gene/pseudogene), [Score=79.7, Expect=1e-14]} {Mouse: ENSMUSG00000079173, Zan, zonadhesin, [Score=80.1, Expect=7e-15]} {RNA1310_18897} {RNA815_40026} |
58. | MligTC455_24753 | 11 | 0.23 | Mlig455_016700 | Neo: - Age: - |
2.635 | - | - | - | 0.788 | 0.961 | 0.886 | Mlig455_016700 {REF} {Length: 1032} {Pfam: PAN domain [PF00024.28, score=20.1]} {RNA1310_36328.1} {RNA815_39270} | |
59. | MligTC455_30137 | 264 | 5.5 | Mlig455_038940 | Neo: - Age: logFC(26M/2M)=-0.387 |
HEATR4 | 2.633 | - | - | - | 0.812 | 0.981 | 0.840 | Mlig455_038940 {REF} {Length: 4881} {TRANSSPLICED} {Pfam: HEAT repeats [PF13646.8, score=79.1]; HEAT repeat [PF02985.24, score=44.0]; HEAT-like repeat [PF13513.8, score=24.2]} {Human: ENSG00000187105, HEATR4, HEAT repeat containing 4, [RH, Score=335, Expect=6e-97]} {Mouse: ENSMUSG00000090843, Heatr4, HEAT repeat containing 4, [RH, Score=328, Expect=5e-95]} {Smed: dd_Smed_v6_16127_0_1, dd_Smed_v6_16127_0_1, [RH, Score=460, Expect=5e-141]} {RNA1509_8516} {RNA1310_8186} {RNA815_1423.1} |
60. | MligTC455_25252 | 56 | 1.17 | Mlig455_041099 | Neo: - |
2.631 | - | - | - | 0.916 | 0.958 | 0.757 | Mlig455_041099 {REF} {Length: 4133} {Pfam: Protein of unknown function (DUF1722) [PF08349.13, score=20.9]} {RNA1509_30687} {RNA1310_3877.1, RNA1509_30687} {RNA1509_30687, RNA815_1645} | |
61. | MligTC455_05098 | 127 | 2.65 | Mlig455_009525, Mlig455_009531 | Neo: - Age: Up-Down-Down Region-enriched R4: 4.095/0.01821 |
KCNH7 | 2.63 | - | - | - | 0.861 | 0.978 | 0.791 | Mlig455_009525 {REF} {Length: 2109} {Pfam: Ion transport protein [PF00520.33, score=111.8]; Ion channel [PF07885.18, score=46.1]; Cyclic nucleotide-binding domain [PF00027.31, score=36.3]; Transcription factor IIA, alpha/beta subunit [PF03153.15, score=29.8]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [Score=528, Expect=4e-176]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [Score=509, Expect=2e-170]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [Score=505, Expect=9e-167]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [Score=527, Expect=4e-175]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [Score=510, Expect=3e-171]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [Score=504, Expect=9e-167]} {Dmel: FBgn0003353, sei, seizure, [Score=507, Expect=2e-171]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [Score=496, Expect=1e-169]} {Smed: dd_Smed_v6_12978_0_1, dd_Smed_v6_12978_0_1, [Score=608, Expect=0.0]} {RNA1509_56964} {RNA1310_41939} {RNA815_5858.1} Mlig455_009531 {REF} {Length: 3631} {Pfam: Ion transport protein [PF00520.33, score=110.4]; Ion channel [PF07885.18, score=45.2]; Cyclic nucleotide-binding domain [PF00027.31, score=43.3]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [Score=619, Expect=0.0]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [Score=597, Expect=0.0]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [Score=596, Expect=0.0]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [Score=617, Expect=0.0]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [Score=602, Expect=0.0]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [Score=596, Expect=0.0]} {Dmel: FBgn0003353, sei, seizure, [Score=591, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [Score=579, Expect=0.0]} {Smed: dd_Smed_v6_12978_0_4, dd_Smed_v6_12978_0_4, [RH, Score=716, Expect=0.0]} {RNA1509_56964} {RNA1310_23186, RNA1509_56964} {RNA1509_56964, RNA815_5858.2} |
62. | MligTC455_19338 | 2431 | 50.65 | Mlig455_022165 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.390 Region-specific R2: 3.133 Region-enriched R2: 2.312/0.00036 |
2.63 | - | - | - | 0.971 | 0.924 | 0.735 | Mlig455_022165 {REF} {Length: 1038} {RNA1509_18606, RNA1509_6523} {RNA1310_50737, RNA1509_18606, RNA1509_6523} {RNA1509_18606, RNA1509_6523, RNA815_26880} | |
63. | MligTC455_24061 | 1104 | 23.01 | Mlig455_017234 | Neo: - Age: - |
SNAP25 | 2.627 | - | - | - | 0.821 | 0.950 | 0.856 | Mlig455_017234 {REF} {Length: 1658} {Pfam: SNAP-25 family [PF00835.21, score=41.5]} {Human: ENSG00000132639, SNAP25, synaptosome associated protein 25, [Score=219, Expect=7e-72]} {Mouse: ENSMUSG00000027273, Snap25, synaptosomal-associated protein 25, [Score=219, Expect=5e-72]} {Dmel: FBgn0266720, Snap24, Synaptosomal-associated protein 24kDa, [RH, Score=228, Expect=1e-75]} {Celegans: WBGene00004364, ric-4, Synaptosomal-associated protein, [RH, Score=257, Expect=2e-87]} {Smed: dd_Smed_v6_3977_0_1, dd_Smed_v6_3977_0_1, [RH, Score=282, Expect=2e-97]} {RNA1509_25321, RNA1509_8624} {RNA1310_24253, RNA1509_25321, RNA1509_8624} {RNA1509_25321, RNA1509_8624, RNA815_10439} |
64. | MligTC455_20390 | 87 | 1.82 | Mlig455_051716 | Neo: - Age: - |
SLC1A2 | 2.625 | - | - | - | 0.801 | 0.956 | 0.868 | Mlig455_051716 {REF} {Length: 4683} {Pfam: Sodium:dicarboxylate symporter family [PF00375.20, score=432.6]} {Human: ENSG00000110436, SLC1A2, solute carrier family 1 member 2, [RH, Score=530, Expect=0.0]} {Mouse: ENSMUSG00000005089, Slc1a2, solute carrier family 1 (glial high affinity glutamate transporter), member 2, [RH, Score=545, Expect=0.0]} {Dmel: FBgn0026439, Eaat1, Excitatory amino acid transporter 1, [RH, Score=375, Expect=4e-124]} {Celegans: WBGene00001620, glt-1, Excitatory amino acid transporter, [RH, Score=517, Expect=1e-179]} {Smed: dd_Smed_v6_7570_0_1, dd_Smed_v6_7570_0_1, [RH, Score=611, Expect=0.0]} {RNA1509_31315} {RNA1310_5180} {RNA815_8754} |
65. | MligTC455_50912 | 113 | 2.35 | Mlig455_007288, Mlig455_007301 | Neo: - Age: - Regeneration-upregulated BL: 5.940 Regeneration-enriched BL: 5.940 |
2.624 | 0.973 | - | - | 0.752 | - | 0.899 | Mlig455_007288 {REF} {Length: 870} {RNA1310_55273} {RNA815_57223} Mlig455_007301 {REF} {Length: 845} {NoTransDecoderORF} {RNA1310_55273} {RNA815_57223} |
|
66. | MligTC455_16415 | 197 | 4.1 | Mlig455_000401 | Neo: - Age: - Region-enriched R2: 4.276/0.00982 |
ROR1 | 2.623 | - | - | - | 0.786 | 0.978 | 0.859 | Mlig455_000401 {REF} {Length: 3780} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=233.3]; Protein kinase domain [PF00069.27, score=85.9]; Immunoglobulin I-set domain [PF07679.18, score=49.4]; Immunoglobulin domain [PF13927.8, score=46.6]; Immunoglobulin domain [PF00047.27, score=31.9]; Immunoglobulin domain [PF13895.8, score=30.0]; Fz domain [PF01392.24, score=27.6]; Kringle domain [PF00051.20, score=22.3]; Immunoglobulin V-set domain [PF07686.19, score=19.5]} {Human: ENSG00000185483, ROR1, receptor tyrosine kinase like orphan receptor 1, [RH, Score=390, Expect=1e-119]; ENSG00000169071, ROR2, receptor tyrosine kinase like orphan receptor 2, [RH, Score=379, Expect=1e-115]} {Mouse: ENSMUSG00000035305, Ror1, receptor tyrosine kinase-like orphan receptor 1, [RH, Score=386, Expect=1e-118]; ENSMUSG00000021464, Ror2, receptor tyrosine kinase-like orphan receptor 2, [RH, Score=377, Expect=4e-115]} {Dmel: FBgn0010407, Ror, [Score=286, Expect=3e-84]} {Celegans: WBGene00000289, cam-1, Tyrosine-protein kinase receptor cam-1, [Score=285, Expect=4e-82]} {Smed: dd_Smed_v6_7911_0_1, dd_Smed_v6_7911_0_1, [RH, Score=439, Expect=2e-139]} {RNA1509_35395} {RNA1310_13558, RNA1509_35395} {RNA1509_35395, RNA815_27446} |
67. | MligTC455_44970 | 1433 | 29.86 | Mlig455_019009 | Neo: - Age: Up-Down-Up Region-enriched R2: 1.095/0.00909 Regeneration-downregulated BL: -1.437 Regeneration-depleted BL: -1.437 |
ATP1B1 | 2.619 | - | - | - | 0.879 | 0.961 | 0.779 | Mlig455_019009 {REF} {Length: 4231} {TRANSSPLICED} {Pfam: Sodium / potassium ATPase beta chain [PF00287.20, score=91.0]} {Human: ENSG00000143153, ATP1B1, ATPase Na+/K+ transporting subunit beta 1, [Score=61.2, Expect=6e-10]} {Mouse: ENSMUSG00000026576, Atp1b1, ATPase, Na+/K+ transporting, beta 1 polypeptide, [Score=61.2, Expect=4e-10]} {Dmel: FBgn0032946, nrv3, nervana 3, [Score=89.4, Expect=8e-20]} {Celegans: WBGene00010117, nkb-3, Probable sodium/potassium-transporting ATPase subunit beta-3, [Score=84.3, Expect=3e-18]} {Smed: dd_Smed_v6_7917_0_1, dd_Smed_v6_7917_0_1, [Score=115, Expect=2e-29]} {RNA1509_10526, RNA1509_49181} {RNA1310_31711, RNA1509_10526, RNA1509_49181} {RNA1509_10526, RNA1509_49181, RNA815_17406} |
68. | MligTC455_53844 | 1403 | 29.24 | Mlig455_051626 | Neo: - |
2.616 | - | - | - | 0.781 | 0.988 | 0.847 | Mlig455_051626 {REF} {Length: 1671} {RNA1509_15580} {RNA1310_24090} {RNA815_10676.2} | |
69. | MligTC455_32445 | 285 | 5.93 | Mlig455_041727, Mlig455_042282 | Neo: - Age: - |
ANK2 | 2.615 | - | - | - | 0.799 | 0.969 | 0.847 | Mlig455_041727 {REF} {Length: 4931} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=276.7]; Ankyrin repeats (many copies) [PF13637.8, score=238.3]; Ankyrin repeat [PF00023.32, score=223.0]; Ankyrin repeats (many copies) [PF13857.8, score=214.9]; Ankyrin repeat [PF13606.8, score=201.4]; Ion transport protein [PF00520.33, score=46.6]} {Human: ENSG00000145362, ANK2, ankyrin 2, [Score=211, Expect=1e-54]} {Mouse: ENSMUSG00000032769, Trpa1, transient receptor potential cation channel, subfamily A, member 1, [Score=290, Expect=2e-80]} {Dmel: FBgn0011747, Ank, Ankyrin, [Score=210, Expect=2e-54]} {Celegans: WBGene00007801, trpa-1, Transient receptor potential cation channel subfamily A member 1 homolog, [Score=489, Expect=7e-151]} {Smed: dd_Smed_v6_6201_0_2, dd_Smed_v6_6201_0_2, [RH, Score=745, Expect=0.0]} {RNA1509_18945} {RNA1310_1506.1, RNA1509_18945} {RNA1509_18945, RNA815_450.1} Mlig455_042282 {REF} {Length: 4940} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=273.8]; Ankyrin repeats (many copies) [PF13637.8, score=232.4]; Ankyrin repeat [PF00023.32, score=218.4]; Ankyrin repeats (many copies) [PF13857.8, score=210.6]; Ankyrin repeat [PF13606.8, score=197.5]; Ion transport protein [PF00520.33, score=46.6]} {Human: ENSG00000145362, ANK2, ankyrin 2, [Score=214, Expect=2e-55]} {Mouse: ENSMUSG00000032826, Ank2, ankyrin 2, brain, [Score=204, Expect=1e-52]; ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=201, Expect=2e-51]} {Dmel: FBgn0011747, Ank, Ankyrin, [Score=205, Expect=6e-53]} {Celegans: WBGene00007801, trpa-1, Transient receptor potential cation channel subfamily A member 1 homolog, [Score=487, Expect=5e-150]} {Smed: dd_Smed_v6_6201_0_2, dd_Smed_v6_6201_0_2, [RH, Score=736, Expect=0.0]} {RNA1509_18945} {RNA1310_1506.1} {RNA815_8298} |
70. | MligTC455_34369 | 112 | 2.34 | Mlig455_015308, Mlig455_015354, Mlig455_036248, Mlig455_068737, Mlig455_070110 | Neo: - Age: Up-Down-Up Region-enriched R2: 5.462/0.00546 |
2.615 | - | - | - | 0.863 | 0.956 | 0.796 | Mlig455_015308 {REF} {Length: 1459} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=63.9]} {RNA1310_34740} {RNA815_15663} Mlig455_015354 {REF} {Length: 1446} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=66.3]; Sialidase, N-terminal domain [PF02973.18, score=18.5]} {RNA1310_34740} {RNA815_15663} Mlig455_036248 {REF} {Length: 2111} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=120.9]; Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=28.5]; PAN domain [PF00024.28, score=19.9]} {RNA1509_45496} {RNA1310_2539.1} {RNA815_252.1} Mlig455_068737 {REF} {Length: 1096} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=68.3]; Sialidase, N-terminal domain [PF02973.18, score=19.9]} {RNA1310_34740} {RNA815_37905} Mlig455_070110 {REF} {Length: 1340} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=109.6]} {RNA1509_32599} {RNA1310_1659} {RNA815_252.1} |
|
71. | MligTC455_29914 | 44 | 0.91 | Mlig455_027923 | Neo: - Age: Down-Up-Down Region-enriched R2: 8.096/0.00455 |
ANGPTL3 | 2.608 | - | - | - | 0.774 | 0.958 | 0.876 | Mlig455_027923 {REF} {Length: 1663} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=70.5]} {Human: ENSG00000132855, ANGPTL3, angiopoietin like 3, [Score=60.5, Expect=9e-10]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=59.3, Expect=2e-09]; ENSG00000120332, TNN, tenascin N, [Score=58.9, Expect=3e-09]} {Mouse: ENSMUSG00000015829, Tnr, tenascin R, [Score=62.4, Expect=2e-10]} {Dmel: FBgn0031804, CG9500, [Score=76.3, Expect=6e-16]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=51.2, Expect=3e-07]} {RNA1509_53291} {RNA1310_58974} {RNA815_43288.3} |
72. | MligTC455_15598 | 45 | 0.94 | Mlig455_021461 | Neo: - Age: Down-Up-Up |
2.607 | - | - | - | 0.865 | 0.968 | 0.774 | Mlig455_021461 {REF} {Length: 2020} {RNA1310_35982.1} {RNA815_27626} | |
73. | MligTC455_48022 | 1337 | 27.86 | Mlig455_045267, Mlig455_069186 | Neo: - Age: - Region-enriched R2: 2.130/0.00146 |
2.605 | - | - | - | 0.917 | 0.962 | 0.726 | Mlig455_045267 {REF} {Length: 3628} {Pfam: Ankyrin repeats (many copies) [PF13857.8, score=29.5]; Ankyrin repeats (many copies) [PF13637.8, score=28.4]; Ankyrin repeats (3 copies) [PF12796.9, score=28.3]; Ankyrin repeat [PF13606.8, score=23.5]} {Celegans: WBGene00009375, F34D10.6, [Score=57.0, Expect=6e-08]} {Smed: dd_Smed_v6_5594_0_3, dd_Smed_v6_5594_0_3, [Score=58.5, Expect=1e-08]} {RNA1509_17412, RNA1509_32079} {RNA1310_5952, RNA1509_17412, RNA1509_32079} {RNA1509_17412, RNA1509_32079, RNA815_2323} Mlig455_069186 {REF} {Length: 3598} {Pfam: Ankyrin repeats (many copies) [PF13637.8, score=30.4]; Ankyrin repeats (3 copies) [PF12796.9, score=30.1]; Ankyrin repeats (many copies) [PF13857.8, score=29.5]; Ankyrin repeat [PF13606.8, score=24.1]} {Celegans: WBGene00009375, F34D10.6, [Score=56.6, Expect=6e-08]} {Smed: dd_Smed_v6_5594_0_4, dd_Smed_v6_5594_0_4, [Score=59.3, Expect=7e-09]} {RNA1509_52963} {RNA1310_5952, RNA1509_52963} {RNA1509_52963, RNA815_2323} |
|
74. | MligTC455_49957 | 119 | 2.47 | Mlig455_005610, Mlig455_014448 | Neo: - Age: - |
2.596 | - | - | - | 0.782 | 0.966 | 0.848 | Mlig455_005610 {REF} {Length: 1455} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=66.2, Expect=4e-13]} {RNA1310_45206} {RNA815_28788} Mlig455_014448 {REF} {Length: 1455} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=63.2, Expect=6e-12]} {RNA1310_45206} {RNA815_28788} |
|
75. | MligTC455_52128 | 26 | 0.54 | Mlig455_056382 | Neo: - Age: - |
2.595 | - | - | - | 0.815 | 0.957 | 0.823 | Mlig455_056382 {REF} {Length: 892} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=20.5]; Ankyrin repeat [PF00023.32, score=19.7]} {RNA1310_149618} | |
76. | MligTC455_47309 | 569 | 11.85 | Mlig455_047902, Mlig455_047990 | Neo: - Age: logFC(26M/2M)=-0.322 |
NSF | 2.594 | - | - | - | 0.898 | 0.964 | 0.732 | Mlig455_047902 {REF} {Length: 3210} {TRANSSPLICED} {Pfam: ATPase family associated with various cellular activities (AAA) [PF00004.31, score=169.7]; AAA+ lid domain [PF17862.3, score=38.2]; AAA ATPase domain [PF13191.8, score=34.7]; Cell division protein 48 (CDC48), N-terminal domain [PF02359.20, score=32.6]; AAA domain [PF13401.8, score=29.7]; AAA domain [PF13173.8, score=29.2]; TIP49 P-loop domain [PF06068.15, score=28.7]; NACHT domain [PF05729.14, score=27.2]; AAA domain (dynein-related subfamily) [PF07728.16, score=26.0]; AAA domain (Cdc48 subfamily) [PF07724.16, score=25.6]; AAA domain [PF13238.8, score=25.5]; AAA domain [PF13671.8, score=22.9]; Threonylcarbamoyl adenosine biosynthesis protein TsaE [PF02367.19, score=22.5]; RNA helicase [PF00910.24, score=22.0]; Holliday junction DNA helicase RuvB P-loop domain [PF05496.14, score=21.8]; Cell division protein 48 (CDC48), domain 2 [PF02933.19, score=21.5]; ATPase domain predominantly from Archaea [PF01637.20, score=21.2]; Magnesium chelatase, subunit ChlI [PF01078.23, score=20.7]} {Human: ENSG00000073969, NSF, N-ethylmaleimide sensitive factor, vesicle fusing ATPase, [RH, Score=759, Expect=0.0]; ENSG00000278174, NSF, N-ethylmaleimide sensitive factor, vesicle fusing ATPase, [RH, Score=759, Expect=0.0]; ENSG00000276262, NSF, N-ethylmaleimide sensitive factor, vesicle fusing ATPase, [RH, Score=759, Expect=0.0]} {Mouse: ENSMUSG00000034187, Nsf, N-ethylmaleimide sensitive fusion protein, [RH, Score=756, Expect=0.0]} {Dmel: FBgn0266464, Nsf2, N-ethylmaleimide-sensitive factor 2, [RH, Score=816, Expect=0.0]} {Celegans: WBGene00003818, nsf-1, Vesicle-fusing ATPase, [RH, Score=676, Expect=0.0]} {Smed: dd_Smed_v6_3364_0_1, dd_Smed_v6_3364_0_1, [RH, Score=631, Expect=0.0]} {RNA1509_35440} {RNA1310_7474} {RNA815_4714} Mlig455_047990 {REF} {Length: 3208} {TRANSSPLICED} {Pfam: ATPase family associated with various cellular activities (AAA) [PF00004.31, score=168.7]; AAA+ lid domain [PF17862.3, score=37.8]; THAP domain [PF05485.14, score=35.8]; AAA ATPase domain [PF13191.8, score=33.6]; Cell division protein 48 (CDC48), N-terminal domain [PF02359.20, score=33.2]; AAA domain [PF13401.8, score=28.4]; AAA domain [PF13173.8, score=28.3]; TIP49 P-loop domain [PF06068.15, score=27.9]; NACHT domain [PF05729.14, score=25.9]; AAA domain (dynein-related subfamily) [PF07728.16, score=25.4]; AAA domain (Cdc48 subfamily) [PF07724.16, score=24.9]; AAA domain [PF13238.8, score=24.7]; AAA domain [PF13671.8, score=22.1]; Threonylcarbamoyl adenosine biosynthesis protein TsaE [PF02367.19, score=21.8]; Cell division protein 48 (CDC48), domain 2 [PF02933.19, score=21.5]; RNA helicase [PF00910.24, score=21.3]; Holliday junction DNA helicase RuvB P-loop domain [PF05496.14, score=21.0]; Magnesium chelatase, subunit ChlI [PF01078.23, score=20.0]; ATPase domain predominantly from Archaea [PF01637.20, score=19.8]} {Human: ENSG00000276262, NSF, N-ethylmaleimide sensitive factor, vesicle fusing ATPase, [RH, Score=760, Expect=0.0]; ENSG00000278174, NSF, N-ethylmaleimide sensitive factor, vesicle fusing ATPase, [RH, Score=760, Expect=0.0]; ENSG00000073969, NSF, N-ethylmaleimide sensitive factor, vesicle fusing ATPase, [RH, Score=760, Expect=0.0]} {Mouse: ENSMUSG00000034187, Nsf, N-ethylmaleimide sensitive fusion protein, [RH, Score=756, Expect=0.0]} {Dmel: FBgn0266464, Nsf2, N-ethylmaleimide-sensitive factor 2, [RH, Score=818, Expect=0.0]} {Celegans: WBGene00003818, nsf-1, Vesicle-fusing ATPase, [RH, Score=677, Expect=0.0]} {Smed: dd_Smed_v6_3364_0_1, dd_Smed_v6_3364_0_1, [RH, Score=630, Expect=0.0]} {RNA1509_35440} {RNA1310_7474} {RNA815_4714} |
77. | MligTC455_13975 | 63 | 1.31 | Mlig455_070810 | Neo: - Age: - Region-enriched R2: 7.513/0.00519 |
2.594 | - | - | - | 0.798 | 0.970 | 0.826 | Mlig455_070810 {REF} {Length: 1542} {Pfam: Otopetrin [PF03189.15, score=108.9]} {Dmel: FBgn0031514, CG3332, [Score=74.3, Expect=3e-14]} {Celegans: WBGene00015035, otpl-1, OToPetrin-Like, [Score=47.8, Expect=9e-06]} {Smed: dd_Smed_v6_13612_0_3, dd_Smed_v6_13612_0_3, [Score=119, Expect=2e-29]} {RNA1310_93602} {RNA815_48323} | |
78. | MligTC455_27692 | 1230 | 25.62 | Mlig455_041598 | Neo: - Age: logFC(26M/2M)=-0.459 Region-enriched R7: 1.679/0.00325 |
TUBA1A | 2.594 | - | - | - | 0.829 | 0.963 | 0.802 | Mlig455_041598 {REF} {Length: 2325} {Pfam: Tubulin/FtsZ family, GTPase domain [PF00091.27, score=229.7]; Tubulin C-terminal domain [PF03953.19, score=175.5]; Tubulin domain [PF14881.8, score=18.9]} {Human: ENSG00000167552, TUBA1A, tubulin alpha 1a, [RH, Score=926, Expect=0.0]; ENSG00000123416, TUBA1B, tubulin alpha 1b, [RH, Score=923, Expect=0.0]; ENSG00000167553, TUBA1C, tubulin alpha 1c, [RH, Score=887, Expect=0.0]} {Mouse: ENSMUSG00000072235, Tuba1a, tubulin, alpha 1A, [RH, Score=926, Expect=0.0]; ENSMUSG00000023004, Tuba1b, tubulin, alpha 1B, [RH, Score=923, Expect=0.0]} {Dmel: FBgn0003884, alphaTub84B, alpha-Tubulin at 84B, [RH, Score=917, Expect=0.0]} {Celegans: WBGene00003175, mec-12, Tubulin alpha-3 chain Detyrosinated tubulin alpha-3 chain, [RH, Score=850, Expect=0.0]} {Smed: dd_Smed_v6_38_0_1, dd_Smed_v6_38_0_1, [RH, Score=924, Expect=0.0]} {RNA1509_21352, RNA1509_42319, RNA1509_9718} {RNA1310_10339.1, RNA1509_21352, RNA1509_42319} {RNA1509_21352, RNA1509_42319, RNA815_1715.1} |
79. | MligTC455_22761 | 288 | 6.01 | Mlig455_005521 | Neo: - Age: - |
ELOVL4 | 2.588 | - | - | - | 0.772 | 0.950 | 0.866 | Mlig455_005521 {REF} {Length: 1592} {TRANSSPLICED} {Pfam: GNS1/SUR4 family [PF01151.20, score=138.3]} {Human: ENSG00000118402, ELOVL4, ELOVL fatty acid elongase 4, [Score=220, Expect=1e-70]} {Mouse: ENSMUSG00000032262, Elovl4, elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 4, [Score=216, Expect=1e-69]} {Dmel: FBgn0052072, Elo68alpha, Elongase 68alpha, [Score=145, Expect=2e-42]} {Celegans: WBGene00001244, elo-6, Elongation of very long chain fatty acids protein 6, [Score=52.8, Expect=4e-08]} {Smed: dd_Smed_v6_7835_0_1, dd_Smed_v6_7835_0_1, [Score=215, Expect=7e-70]} {RNA1509_11261} {RNA1310_42181} {RNA815_6649.1} |
80. | MligTC455_16813 | 75 | 1.56 | Mlig455_049094 | Neo: - Age: - |
NMUR2 | 2.583 | - | - | - | 0.855 | 0.980 | 0.748 | Mlig455_049094 {REF} {Length: 1759} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=148.5]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=34.9]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=25.8]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=21.2]} {Human: ENSG00000132911, NMUR2, neuromedin U receptor 2, [RH, Score=161, Expect=3e-44]} {Mouse: ENSMUSG00000037393, Nmur2, neuromedin U receptor 2, [RH, Score=176, Expect=6e-50]} {Dmel: FBgn0038140, PK2-R1, Pyrokinin 2 receptor 1, [RH, Score=213, Expect=6e-62]} {Celegans: WBGene00016747, nmur-1, NMUR (NeuroMedin U Receptor) homolog; Neuromedin U receptor, [RH, Score=177, Expect=2e-50]} {Smed: dd_Smed_v6_17801_0_1, dd_Smed_v6_17801_0_1, [Score=159, Expect=5e-44]} {RNA1310_33884} {RNA815_14436} |
81. | MligTC455_03841 | 920 | 19.16 | Mlig455_018790, Mlig455_048140 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.474 Region-enriched R2: 5.915/0.00081 |
NKX2-1, NKX2-4 | 2.579 | - | - | - | 0.865 | 0.980 | 0.734 | Mlig455_018790 {REF} {Length: 2203} {Pfam: Homeodomain [PF00046.31, score=72.7]} {Human: ENSG00000136352, NKX2-1, NK2 homeobox 1, [RH, Score=145, Expect=2e-39]; ENSG00000125816, NKX2-4, NK2 homeobox 4, [RH, Score=145, Expect=2e-39]} {Mouse: ENSMUSG00000001496, Nkx2-1, NK2 homeobox 1, [RH, Score=145, Expect=2e-39]} {Dmel: FBgn0028993, scro, scarecrow, [RH, Score=166, Expect=8e-47]} {Celegans: WBGene00000447, ceh-24, Homeobox protein ceh-24, [RH, Score=134, Expect=2e-36]} {Smed: dd_Smed_v6_6729_0_1, dd_Smed_v6_6729_0_1, [RH, Score=191, Expect=1e-57]} {RNA1509_12761} {RNA1310_13401} {RNA815_21584} Mlig455_048140 {REF} {Length: 2218} {Pfam: Homeodomain [PF00046.31, score=72.5]} {Human: ENSG00000125816, NKX2-4, NK2 homeobox 4, [RH, Score=145, Expect=3e-39]; ENSG00000136352, NKX2-1, NK2 homeobox 1, [RH, Score=145, Expect=7e-39]} {Mouse: ENSMUSG00000001496, Nkx2-1, NK2 homeobox 1, [RH, Score=144, Expect=6e-39]} {Dmel: FBgn0028993, scro, scarecrow, [RH, Score=166, Expect=2e-46]} {Celegans: WBGene00000447, ceh-24, Homeobox protein ceh-24, [RH, Score=136, Expect=1e-36]} {Smed: dd_Smed_v6_6729_0_1, dd_Smed_v6_6729_0_1, [RH, Score=193, Expect=1e-57]} {RNA1509_12761} {RNA1310_13401, RNA1509_12761} {RNA1509_12761, RNA815_21584} |
82. | MligTC455_16416 | 290 | 6.04 | Mlig455_000468 | Neo: - Age: - Region-enriched R2: 2.225/0.04782 |
ROR1 | 2.575 | - | - | - | 0.753 | 0.980 | 0.842 | Mlig455_000468 {REF} {Length: 2686} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=208.1]; Protein kinase domain [PF00069.27, score=77.3]; Kringle domain [PF00051.20, score=19.4]} {Human: ENSG00000185483, ROR1, receptor tyrosine kinase like orphan receptor 1, [Score=300, Expect=1e-89]} {Mouse: ENSMUSG00000035305, Ror1, receptor tyrosine kinase-like orphan receptor 1, [Score=295, Expect=2e-87]; ENSMUSG00000021464, Ror2, receptor tyrosine kinase-like orphan receptor 2, [Score=281, Expect=2e-82]} {Dmel: FBgn0010407, Ror, [Score=259, Expect=2e-76]} {Celegans: WBGene00000289, cam-1, Tyrosine-protein kinase receptor cam-1, [Score=217, Expect=2e-60]} {Smed: dd_Smed_v6_7911_0_1, dd_Smed_v6_7911_0_1, [Score=328, Expect=1e-100]} {RNA1509_35395} {RNA1310_13558} {RNA815_27446} |
83. | MligTC455_30365 | 335 | 6.99 | Mlig455_005426 | Neo: - Age: - |
C20orf194 | 2.569 | 0.951 | - | - | 0.788 | 0.830 | - | Mlig455_005426 {REF} {Length: 2028} {TRANSSPLICED} {Human: ENSG00000088854, C20orf194, chromosome 20 open reading frame 194, [Score=100, Expect=2e-21]} {Mouse: ENSMUSG00000027309, 4930402H24Rik, RIKEN cDNA 4930402H24 gene, [RH, Score=108, Expect=4e-24]} {Smed: dd_Smed_v6_10121_0_1, dd_Smed_v6_10121_0_1, [Score=88.2, Expect=5e-18]} {RNA1509_29925} {RNA1310_1263.1} {RNA815_15442} |
84. | MligTC455_52656 | 121 | 2.51 | Mlig455_062381, Mlig455_062408 | Neo: - Age: Down-Up-Down |
2.567 | - | - | - | 0.703 | 0.959 | 0.905 | Mlig455_062381 {REF} {Length: 2245} {RNA1310_26272} {RNA815_22826} Mlig455_062408 {REF} {Length: 2277} {RNA1310_26272} {RNA815_37592} |
|
85. | MligTC455_32685 | 505 | 10.53 | Mlig455_057075 | Neo: - Age: Up-Down-Up |
2.562 | - | - | - | 0.954 | 0.820 | 0.788 | Mlig455_057075 {REF} {Length: 7466} {Pfam: REJ domain [PF02010.17, score=62.8]} {RNA1509_14190, RNA1509_21224, RNA1509_37446, RNA1509_40150} {RNA1310_402.1, RNA1509_14190, RNA1509_21224, RNA1509_37446, RNA1509_40150} {RNA1509_14190, RNA1509_21224, RNA1509_37446, RNA1509_40150, RNA815_93.1} | |
86. | MligTC455_52628 | 1017 | 21.18 | Mlig455_032069, Mlig455_070292 | Neo: - Age: logFC(26M/2M)=0.328 Region-enriched R2: 2.815/0.01311 |
CCDC65 | 2.553 | - | - | - | 0.969 | 0.746 | 0.838 | Mlig455_032069 {REF} {Length: 1945} {TRANSSPLICED} {Pfam: Sperm tail [PF14772.8, score=83.3]; Sperm tail C-terminal domain [PF14775.8, score=31.7]} {Human: ENSG00000139537, CCDC65, coiled-coil domain containing 65, [RH, Score=400, Expect=6e-135]} {Mouse: ENSMUSG00000003354, Ccdc65, coiled-coil domain containing 65, [RH, Score=412, Expect=2e-139]} {Dmel: FBgn0050259, CG30259, [Score=149, Expect=1e-38]} {Smed: dd_Smed_v6_6152_0_1, dd_Smed_v6_6152_0_1, [RH, Score=504, Expect=7e-176]} {RNA1509_41957} {RNA1310_14751, RNA1509_41957} {RNA1509_41957, RNA815_5754} Mlig455_070292 {REF} {Length: 1888} {TRANSSPLICED} {Pfam: Sperm tail [PF14772.8, score=83.3]; Sperm tail C-terminal domain [PF14775.8, score=31.7]} {Human: ENSG00000139537, CCDC65, coiled-coil domain containing 65, [RH, Score=399, Expect=3e-134]} {Mouse: ENSMUSG00000003354, Ccdc65, coiled-coil domain containing 65, [RH, Score=410, Expect=1e-138]} {Dmel: FBgn0050259, CG30259, [RH, Score=150, Expect=3e-39]} {Smed: dd_Smed_v6_6152_0_1, dd_Smed_v6_6152_0_1, [RH, Score=501, Expect=7e-175]} {RNA1509_11616} {RNA1310_14751, RNA1509_11616} {RNA1509_11616, RNA815_5754} |
87. | MligTC455_26253 | 375 | 7.81 | Mlig455_009976 | Neo: - Age: - |
FZD5 | 2.551 | 0.982 | - | - | - | 0.721 | 0.848 | Mlig455_009976 {REF} {Length: 4082} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=407.2]; Fz domain [PF01392.24, score=99.7]} {Human: ENSG00000163251, FZD5, frizzled class receptor 5, [RH, Score=605, Expect=0.0]} {Mouse: ENSMUSG00000045005, Fzd5, frizzled class receptor 5, [RH, Score=607, Expect=0.0]} {Dmel: FBgn0016797, fz2, frizzled 2, [RH, Score=402, Expect=2e-130]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [RH, Score=417, Expect=8e-139]} {Smed: dd_Smed_v6_11823_0_1, dd_Smed_v6_11823_0_1, [RH, Score=551, Expect=0.0]} {RNA1509_25697, RNA1509_59712} {RNA1310_9946, RNA1509_25697} {RNA1509_25697, RNA815_7287} |
88. | MligTC455_55962 | 215 | 4.49 | Mlig455_005420 | Neo: - Age: - |
2.534 | 0.957 | - | - | 0.835 | 0.742 | - | Mlig455_005420 {REF} {Length: 1} {TRANSSPLICED} {NoTransDecoderORF} | |
89. | MligTC455_49514 | 319 | 6.65 | Mlig455_044307 | Neo: - Age: - |
AGBL2 | 2.532 | 0.952 | - | - | 0.711 | 0.869 | - | Mlig455_044307 {REF} {Length: 4376} {Pfam: Cytosolic carboxypeptidase N-terminal domain [PF18027.3, score=73.3]; Zinc carboxypeptidase [PF00246.26, score=65.6]} {Human: ENSG00000285501, AGBL2, ATP/GTP binding protein like 2, [Score=560, Expect=0.0]; ENSG00000165923, AGBL2, ATP/GTP binding protein like 2, [Score=560, Expect=0.0]; ENSG00000146856, AGBL3, ATP/GTP binding protein like 3, [Score=535, Expect=7e-173]} {Mouse: ENSMUSG00000040812, Agbl2, ATP/GTP binding protein-like 2, [Score=556, Expect=0.0]; ENSMUSG00000038836, Agbl3, ATP/GTP binding protein-like 3, [Score=540, Expect=8e-174]} {Dmel: FBgn0265726, Nna1, Nna1 carboxypeptidase, [Score=538, Expect=1e-176]} {Celegans: WBGene00018995, ccpp-1, Cytosolic carboxypeptidase 1, [Score=267, Expect=3e-74]} {Smed: dd_Smed_v6_13450_0_1, dd_Smed_v6_13450_0_1, [Score=585, Expect=0.0]} {RNA1509_10895} {RNA1310_1654.2} {RNA815_1445.1} |
90. | MligTC455_47160 | 747 | 15.56 | Mlig455_021750 | Neo: - Age: logFC(26M/2M)=-0.246 |
FAM184A | 2.531 | - | - | - | 0.802 | 0.968 | 0.761 | Mlig455_021750 {REF} {Length: 3705} {Pfam: Family with sequence similarity 184, A and B [PF15665.7, score=130.1]} {Human: ENSG00000111879, FAM184A, family with sequence similarity 184 member A, [RH, Score=340, Expect=5e-99]} {Mouse: ENSMUSG00000019856, Fam184a, family with sequence similarity 184, member A, [RH, Score=308, Expect=7e-88]} {Celegans: WBGene00001328, epi-1, Laminin-like protein epi-1, [Score=60.8, Expect=5e-09]} {Smed: dd_Smed_v6_16975_0_1, dd_Smed_v6_16975_0_1, [RH, Score=264, Expect=3e-73]} {RNA1509_5806} {RNA1310_3258.1, RNA1509_5806} {RNA1509_5806, RNA815_936} |
91. | MligTC455_16248 | 132 | 2.74 | Mlig455_038325, Mlig455_050222, Mlig455_050231 | Neo: - Age: - |
CHRNA3 | 2.528 | - | 0.816 | - | 0.736 | 0.976 | - | Mlig455_038325 {REF} {Length: 1078} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=200.0]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=192, Expect=4e-57]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=194, Expect=7e-58]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=190, Expect=1e-56]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=206, Expect=1e-62]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=186, Expect=4e-55]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=216, Expect=5e-67]} {RNA1310_44575} {RNA815_22042} Mlig455_050222 {REF} {Length: 2164} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=202.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=197.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=348, Expect=5e-114]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=335, Expect=4e-109]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=348, Expect=2e-114]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=343, Expect=2e-112]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=335, Expect=5e-109]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=397, Expect=1e-133]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=338, Expect=2e-110]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=489, Expect=5e-170]} {RNA1310_44575} {RNA815_22042} Mlig455_050231 {REF} {Length: 2219} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=203.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=143.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=304, Expect=5e-99]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=299, Expect=8e-97]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=293, Expect=2e-94]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=290, Expect=7e-92]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=302, Expect=3e-98]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=296, Expect=3e-96]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=291, Expect=5e-94]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=352, Expect=8e-117]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=303, Expect=5e-99]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=424, Expect=2e-146]} {RNA1310_44575} {RNA815_22042} |
92. | MligTC455_54202 | 381 | 7.94 | Mlig455_006349 | Neo: - Age: logFC(26M/2M)=0.343 Region-specific R2: 5.916 Region-enriched R2: 5.229/0.00037 |
MYH6 | 2.524 | - | 0.707 | - | 0.849 | 0.968 | - | Mlig455_006349 {REF} {Length: 6943} {Pfam: Myosin head (motor domain) [PF00063.23, score=929.0]; Myosin tail [PF01576.21, score=591.7]; Myosin N-terminal SH3-like domain [PF02736.21, score=60.7]; Crescentin protein [PF19220.2, score=26.4]; Autophagy protein 16 (ATG16) [PF08614.13, score=20.3]; Macoilin family [PF09726.11, score=18.3]} {Human: ENSG00000197616, MYH6, myosin heavy chain 6, [RH, Score=2075, Expect=0.0]; ENSG00000092054, MYH7, myosin heavy chain 7, [RH, Score=2066, Expect=0.0]; ENSG00000125414, MYH2, myosin heavy chain 2, [RH, Score=2021, Expect=0.0]; ENSG00000109061, MYH1, myosin heavy chain 1, [RH, Score=2013, Expect=0.0]; ENSG00000133020, MYH8, myosin heavy chain 8, [RH, Score=2007, Expect=0.0]; ENSG00000264424, MYH4, myosin heavy chain 4, [RH, Score=1993, Expect=0.0]; ENSG00000109063, MYH3, myosin heavy chain 3, [RH, Score=1974, Expect=0.0]} {Mouse: ENSMUSG00000040752, Myh6, myosin, heavy polypeptide 6, cardiac muscle, alpha, [RH, Score=2076, Expect=0.0]; ENSMUSG00000053093, Myh7, myosin, heavy polypeptide 7, cardiac muscle, beta, [RH, Score=2063, Expect=0.0]; ENSMUSG00000057003, Myh4, myosin, heavy polypeptide 4, skeletal muscle, [RH, Score=2041, Expect=0.0]; ENSMUSG00000056328, Myh1, myosin, heavy polypeptide 1, skeletal muscle, adult, [RH, Score=2018, Expect=0.0]; ENSMUSG00000055775, Myh8, myosin, heavy polypeptide 8, skeletal muscle, perinatal, [RH, Score=2015, Expect=0.0]; ENSMUSG00000033196, Myh2, myosin, heavy polypeptide 2, skeletal muscle, adult, [RH, Score=2009, Expect=0.0]; ENSMUSG00000020908, Myh3, myosin, heavy polypeptide 3, skeletal muscle, embryonic, [RH, Score=1981, Expect=0.0]; ENSMUSG00000060180, Myh13, myosin, heavy polypeptide 13, skeletal muscle, [RH, Score=1979, Expect=0.0]} {Dmel: FBgn0264695, Mhc, Myosin heavy chain, [RH, Score=2100, Expect=0.0]} {Celegans: WBGene00019064, myo-5, MYOsin heavy chain structural genes, [RH, Score=1996, Expect=0.0]} {Smed: dd_Smed_v6_579_0_1, dd_Smed_v6_579_0_1, [RH, Score=2705, Expect=0.0]} {RNA1509_16048, RNA1509_54239, RNA1509_55838} {RNA1310_1388, RNA1509_16048, RNA1509_54239, RNA1509_55838} {RNA1509_16048, RNA1509_54239, RNA1509_55838, RNA815_129.1} |
93. | MligTC455_19708 | 304 | 6.32 | Mlig455_009784 | Neo: - Age: - Region-enriched R2: 6.355/0.00039 |
2.521 | - | - | - | 0.739 | 0.951 | 0.831 | Mlig455_009784 {REF} {Length: 826} {Pfam: Pancreatic hormone peptide [PF00159.20, score=43.3]} {RNA1509_54211} {RNA1310_54505.1, RNA1509_54211} {RNA1509_54211, RNA815_29389} | |
94. | MligTC455_34524 | 155 | 3.22 | Mlig455_021291 | Neo: - Age: Down-Up-Down Region-specific R2: 4.905 Region-enriched R2: 4.200/0.01842 |
2.52 | - | - | - | 0.722 | 0.953 | 0.845 | Mlig455_021291 {REF} {Length: 1478} {NoTransDecoderORF} {RNA1509_56543} {RNA1310_26920, RNA1509_56543} {RNA1509_56543, RNA815_11718} | |
95. | MligTC455_17561 | 189 | 3.94 | Mlig455_020268 | Neo: - Age: - Region-enriched R2: 4.198/0.00004 |
NECAB3 | 2.518 | - | 0.730 | - | 0.816 | 0.972 | - | Mlig455_020268 {REF} {Length: 1518} {Pfam: EF hand [PF00036.34, score=34.0]; EF-hand domain [PF13405.8, score=33.4]; EF-hand domain pair [PF13833.8, score=29.2]; EF-hand domain pair [PF13499.8, score=28.3]; Antibiotic biosynthesis monooxygenase [PF03992.18, score=22.0]; EF hand [PF13202.8, score=21.3]} {Human: ENSG00000125967, NECAB3, N-terminal EF-hand calcium binding protein 3, [RH, Score=189, Expect=7e-57]; ENSG00000123119, NECAB1, N-terminal EF-hand calcium binding protein 1, [RH, Score=186, Expect=1e-55]} {Mouse: ENSMUSG00000040536, Necab1, N-terminal EF-hand calcium binding protein 1, [RH, Score=192, Expect=6e-58]; ENSMUSG00000027489, Necab3, N-terminal EF-hand calcium binding protein 3, [RH, Score=191, Expect=9e-58]} {RNA1509_46831} {RNA1310_24461, RNA1509_46831} {RNA1509_46831, RNA815_25216} |
96. | MligTC455_28168 | 822 | 17.12 | Mlig455_023828 | Neo: - Age: - |
2.516 | 0.841 | - | - | 0.720 | 0.955 | - | Mlig455_023828 {REF} {Length: 3967} {Smed: dd_Smed_v6_6429_0_1, dd_Smed_v6_6429_0_1, [Score=99.0, Expect=5e-22]} {RNA1509_9848} {RNA1310_8221} {RNA815_6368.1} | |
97. | MligTC455_33343 | 459 | 9.56 | Mlig455_063303 | Neo: - Age: - Region-enriched R2: 1.600/0.01675 |
ITPR1 | 2.514 | 0.736 | - | - | 0.811 | 0.967 | - | Mlig455_063303 {REF} {Length: 3962} {Pfam: RyR and IP3R Homology associated [PF08454.13, score=68.3]; Ion transport protein [PF00520.33, score=28.7]} {Human: ENSG00000150995, ITPR1, inositol 1,4,5-trisphosphate receptor type 1, [Score=166, Expect=6e-41]} {Mouse: ENSMUSG00000030102, Itpr1, inositol 1,4,5-trisphosphate receptor 1, [Score=182, Expect=7e-46]} {Dmel: FBgn0010051, Itp-r83A, Inositol 1,4,5,-tris-phosphate receptor, [Score=179, Expect=4e-45]} {Celegans: WBGene00002173, itr-1, Inositol 1,4,5-trisphosphate receptor itr-1, [Score=155, Expect=5e-38]} {Smed: dd_Smed_v6_3814_1_1, dd_Smed_v6_3814_1_1, [Score=1044, Expect=0.0]} {RNA1509_30811} {RNA1310_939} {RNA815_220} |
98. | MligTC455_33880 | 65 | 1.35 | Mlig455_057597 | Neo: - Age: - |
GRIN2A | 2.504 | 0.968 | - | - | 0.732 | 0.804 | - | Mlig455_057597 {REF} {Length: 4580} {Pfam: Ligand-gated ion channel [PF00060.28, score=102.0]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=81.1]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=74.4]; Receptor family ligand binding region [PF01094.30, score=30.9]} {Human: ENSG00000183454, GRIN2A, glutamate ionotropic receptor NMDA type subunit 2A, [RH, Score=340, Expect=2e-96]; ENSG00000273079, GRIN2B, glutamate ionotropic receptor NMDA type subunit 2B, [RH, Score=335, Expect=8e-95]; ENSG00000105464, GRIN2D, glutamate ionotropic receptor NMDA type subunit 2D, [RH, Score=330, Expect=3e-93]} {Mouse: ENSMUSG00000059003, Grin2a, glutamate receptor, ionotropic, NMDA2A (epsilon 1), [RH, Score=342, Expect=4e-97]; ENSMUSG00000002771, Grin2d, glutamate receptor, ionotropic, NMDA2D (epsilon 4), [RH, Score=335, Expect=2e-95]; ENSMUSG00000030209, Grin2b, glutamate receptor, ionotropic, NMDA2B (epsilon 2), [RH, Score=335, Expect=9e-95]} {Dmel: FBgn0053513, Nmdar2, NMDA receptor 2, [RH, Score=534, Expect=7e-170]} {Celegans: WBGene00003775, nmr-2, NMDA class glutamate Receptor; NMDA-type ionotropic glutamate receptor NMR-2, [RH, Score=478, Expect=6e-150]} {Smed: dd_Smed_v6_11481_0_1, dd_Smed_v6_11481_0_1, [RH, Score=900, Expect=0.0]} {RNA1509_23999} {RNA1310_1305.1, RNA1509_23999} {RNA1509_23999, RNA815_19439} |
99. | MligTC455_50601 | 21 | 0.44 | Mlig455_018462 | Neo: - Age: - |
2.504 | - | 0.701 | - | 0.832 | 0.971 | - | Mlig455_018462 {REF} {Length: 2878} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=164.0]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [Score=117, Expect=1e-27]} {RNA1310_8235} {RNA815_10456.1} | |
100. | MligTC455_43072 | 81 | 1.68 | Mlig455_042521 | Neo: - Age: Down-Up-Down Region-enriched R2: 5.590/0.02161 |
2.499 | - | - | - | 0.702 | 0.957 | 0.840 | Mlig455_042521 {REF} {Length: 1049} {RNA1509_46101} {RNA1310_32444} {RNA815_30668} |